24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      New Understanding of β-Cell Heterogeneity and In Situ Islet Function

      discussion
      1 , 2 , 3 , 4 , 5
      Diabetes
      American Diabetes Association

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Insulin-secreting β-cells are heterogeneous in their regulation of hormone release. While long known, recent technological advances and new markers have allowed the identification of novel subpopulations, improving our understanding of the molecular basis for heterogeneity. This includes specific subpopulations with distinct functional characteristics, developmental programs, abilities to proliferate in response to metabolic or developmental cues, and resistance to immune-mediated damage. Importantly, these subpopulations change in disease or aging, including in human disease. Although discovering new β-cell subpopulations has substantially advanced our understanding of islet biology, a point of caution is that these characteristics have often necessarily been identified in single β-cells dissociated from the islet. β-Cells in the islet show extensive communication with each other via gap junctions and with other cell types via diffusible chemical messengers. As such, how these different subpopulations contribute to in situ islet function, including during plasticity, is not well understood. We will discuss recent findings revealing functional β-cell subpopulations in the intact islet, the underlying basis for these identified subpopulations, and how these subpopulations may influence in situ islet function. Furthermore, we will discuss the outlook for emerging technologies to gain further insight into the role of subpopulations in in situ islet function.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes.

          Pancreatic islet cells are critical for maintaining normal blood glucose levels, and their malfunction underlies diabetes development and progression. We used single-cell RNA sequencing to determine the transcriptomes of 1,492 human pancreatic α, β, δ, and PP cells from non-diabetic and type 2 diabetes organ donors. We identified cell-type-specific genes and pathways as well as 245 genes with disturbed expression in type 2 diabetes. Importantly, 92% of the genes have not previously been associated with islet cell function or growth. Comparison of gene profiles in mouse and human α and β cells revealed species-specific expression. All data are available for online browsing and download and will hopefully serve as a resource for the islet research community.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose

            Summary The arrangement of β cells within islets of Langerhans is critical for insulin release through the generation of rhythmic activity. A privileged role for individual β cells in orchestrating these responses has long been suspected, but not directly demonstrated. We show here that the β cell population in situ is operationally heterogeneous. Mapping of islet functional architecture revealed the presence of hub cells with pacemaker properties, which remain stable over recording periods of 2 to 3 hr. Using a dual optogenetic/photopharmacological strategy, silencing of hubs abolished coordinated islet responses to glucose, whereas specific stimulation restored communication patterns. Hubs were metabolically adapted and targeted by both pro-inflammatory and glucolipotoxic insults to induce widespread β cell dysfunction. Thus, the islet is wired by hubs, whose failure may contribute to type 2 diabetes mellitus.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Identification of proliferative and mature β-cells in the islets of Langerhans.

              Insulin-dependent diabetes is a complex multifactorial disorder characterized by loss or dysfunction of β-cells. Pancreatic β-cells differ in size, glucose responsiveness, insulin secretion and precursor cell potential; understanding the mechanisms that underlie this functional heterogeneity might make it possible to develop new regenerative approaches. Here we show that Fltp (also known as Flattop and Cfap126), a Wnt/planar cell polarity (PCP) effector and reporter gene acts as a marker gene that subdivides endocrine cells into two subpopulations and distinguishes proliferation-competent from mature β-cells with distinct molecular, physiological and ultrastructural features. Genetic lineage tracing revealed that endocrine subpopulations from Fltp-negative and -positive lineages react differently to physiological and pathological changes. The expression of Fltp increases when endocrine cells cluster together to form polarized and mature 3D islet mini-organs. We show that 3D architecture and Wnt/PCP ligands are sufficient to trigger β-cell maturation. By contrast, the Wnt/PCP effector Fltp is not necessary for β-cell development, proliferation or maturation. We conclude that 3D architecture and Wnt/PCP signalling underlie functional β-cell heterogeneity and induce β-cell maturation. The identification of Fltp as a marker for endocrine subpopulations sheds light on the molecular underpinnings of islet cell heterogeneity and plasticity and might enable targeting of endocrine subpopulations for the regeneration of functional β-cell mass in diabetic patients.
                Bookmark

                Author and article information

                Journal
                Diabetes
                Diabetes
                diabetes
                diabetes
                Diabetes
                Diabetes
                American Diabetes Association
                0012-1797
                1939-327X
                April 2018
                13 March 2018
                : 67
                : 4
                : 537-547
                Affiliations
                [1] 1Department of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, CO
                [2] 2Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO
                [3] 3Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, U.K.
                [4] 4Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, U.K.
                [5] 5Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Birmingham, U.K.
                Author notes
                Corresponding authors: Richard K.P. Benninger, richard.benninger@ 123456ucdenver.edu , and David J. Hodson, d.hodson@ 123456bham.ac.uk .
                Author information
                http://orcid.org/0000-0002-5063-6096
                http://orcid.org/0000-0002-8641-8568
                Article
                0040
                10.2337/dbi17-0040
                5860861
                29559510
                ffe34981-8690-435b-9a87-996caa4a4d83
                © 2018 by the American Diabetes Association.

                Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

                History
                : 28 September 2017
                : 28 December 2017
                Page count
                Figures: 3, Tables: 0, Equations: 0, References: 55, Pages: 11
                Funding
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases, DOI http://dx.doi.org/10.13039/100000062;
                Award ID: R01 DK102950
                Award ID: R01 DK106412
                Funded by: National Institutes of Health Office of the Director, DOI http://dx.doi.org/10.13039/100000052;
                Award ID: OT2 TR001991
                Funded by: JDRF, DOI http://dx.doi.org/10.13039/100008871;
                Award ID: 5-CDA-2014-198-A-N
                Award ID: 1-INO-2017-435-A-N
                Funded by: Diabetes UK, DOI http://dx.doi.org/10.13039/501100000361;
                Award ID: 12/0004431
                Funded by: Wellcome Trust, DOI http://dx.doi.org/10.13039/100004440;
                Award ID: Institutional Support Award
                Funded by: Medical Research Council, DOI http://dx.doi.org/10.13039/501100000265;
                Award ID: MR/N00275X/1
                Funded by: Horizon 2020 European Research Council, DOI http://dx.doi.org/10.13039/100010663;
                Award ID: 715884
                Categories
                0711
                Perspectives in Diabetes

                Endocrinology & Diabetes
                Endocrinology & Diabetes

                Comments

                Comment on this article